Google
UPB — UPSTREAM BIO, INC. (Healthcare >> Biotechnology)
UPB FAQ
What is UPB's ROE?
UPSTREAM BIO, INC. reports a Return on Equity (ROE) of -51.57%.
What is UPB's dividend yield?
UPSTREAM BIO, INC. offers a dividend yield of 0.00%.
What is UPB's Deepscope Quality Score?
Deepscope rates UPB's overall financial quality at 15 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy UPB?
Deepscope's AI Timing Score for UPB is 26 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does UPB belong to?
UPSTREAM BIO, INC. is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 7.05
Price
-0.38
(-5.11%)
Day Change
|
|
|---|
UPB, the overall quality is not good ( Quality = 15) and the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROE is relatively low.
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
Negative growth of ROE in the last year.
ROE is decreasing significantly
ROA is too relatively low compare to ROE
Growth of ROA was below our criteria in the last year.
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Historical net profit margin is relatively low.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is ok , ...
| Quality Factors |
|
47% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 89 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 7.05 |
| PBV / Sector |
1.37 / 4.63
GOOD
|
| Earning Per Share | -2.66 |
| PE / Sector |
N/A / 17.43
|
| PEG or PE/Growth / Sector |
N/A / 0.53
|
| Average 1M Daily Value |
4.65 M
GREAT
|
| Average 1W Daily Value |
4.55 M
GREAT
|
| Timing Factors |
|
28% |
| Financial Health |
|
41% |
| Ability to Make Profit |
|
60% |
| Return to Investors |
|
8% |
| Registration Details |
| Analyze Date | 2026-06-06 09:08:30 |
| Symbol | UPB |
| Name | UPSTREAM BIO, INC. |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 54.42 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 415.22 / 8,857.28 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 890 Winter Street, Waltham, MA, United States, 02451
Phone: 781 208 2466
Website: https://upstreambio.com
Employees: 75
Sector: Healthcare >> Biotechnology
Description: Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders. It offers verekitug, which is in Phase 2 trials for the treatment of severe asthma and chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease and in Phase I clinical trial for treating chronic obstructive pulmonary disease. The company was incorporated in 2021 and is headquartered in Waltham, Massachusetts.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
